ibacitabine has been researched along with ganciclovir in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klatzmann, D; Meur, MR; Noguiez-Hellin, P; Salzmann, JL | 1 |
Eskerski, H; Haberkorn, U; Kleinschmidt, J; Mier, W; Paschen, A; Rothfels, H; Schadendorf, D; Schoensiegel, F; Sieger, S | 1 |
2 other study(ies) available for ibacitabine and ganciclovir
Article | Year |
---|---|
Plasmoviruses: nonviral/viral vectors for gene therapy.
Topics: 3T3 Cells; Animals; Antiviral Agents; beta-Galactosidase; Bromodeoxycytidine; Cell Line; Cell Transformation, Neoplastic; Deoxycytidine; DNA Replication; Ganciclovir; Genes, env; Genetic Therapy; Genetic Vectors; Male; Mice; Mice, Inbred BALB C; Moloney murine leukemia virus; Neoplasms, Experimental; Plasmids; Proviruses; Recombinant Proteins; Retroviridae; Simplexvirus; Thymidine Kinase; Transfection; Virus Replication | 1996 |
MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
Topics: Animals; Antiviral Agents; Bromodeoxycytidine; Cell Line, Tumor; Cell Separation; Cloning, Molecular; Deoxycytidine; Dependovirus; Enhancer Elements, Genetic; Extracellular Matrix Proteins; Female; Flow Cytometry; Ganciclovir; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Humans; Immunosuppressive Agents; Melanoma; Mice; Mice, Nude; Models, Genetic; Monophenol Monooxygenase; Neoplasm Proteins; Neoplasm Transplantation; Plasmids; Promoter Regions, Genetic; Proteins; Simplexvirus; Thymidine Kinase; Time Factors; Tissue Distribution | 2004 |